1.09
前日終値:
$1.09
開ける:
$1.1
24時間の取引高:
625.85K
Relative Volume:
0.82
時価総額:
$212.83M
収益:
$4.71M
当期純損益:
$-58.01M
株価収益率:
-1.3238
EPS:
-0.8234
ネットキャッシュフロー:
$-46.68M
1週間 パフォーマンス:
+4.81%
1か月 パフォーマンス:
-4.39%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
-12.80%
Lucid Diagnostics Inc Stock (LUCD) Company Profile
Compare LUCD vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
LUCD
Lucid Diagnostics Inc
|
1.09 | 212.83M | 4.71M | -58.01M | -46.68M | -0.8234 |
|
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
|
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-12-27 | 開始されました | Ascendiant Capital Markets | Buy |
| 2021-11-08 | 開始されました | BTIG Research | Buy |
| 2021-11-08 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-11-08 | 開始されました | Needham | Buy |
Lucid Diagnostics Inc (LUCD) 最新ニュース
Q3 2025 PAVmed Inc Earnings Call Transcript - GuruFocus
PAVmed will outline Q1 results and strategy in a May 15 webcast - Stock Titan
Lucid Diagnostics (NASDAQ: LUCD) seeks big share increase in 2026 proxy - Stock Titan
Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026 - BioSpace
Lucid Diagnostics will detail Q1 results and strategy on May 14 - Stock Titan
Lucid nearing Medicare coverage for EsoGuard test, maintain at Buy: BTIG - MSN
Lucid Diagnostics closes underwritten offering of common stock - Medical Buyer
Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock - marketscreener.com
Lucid Diagnostics Raises Capital Through Direct Share Offering - The Globe and Mail
Lucid Diagnostics closes $18M stock offering at $1 per share - Investing.com Australia
Lucid Diagnostics (LUCD) CMO reports 650K restricted shares and 100K options - Stock Titan
Lucid Diagnostics closes $18M underwritten offering, issues 18M shares at $1.00 - TradingView
Lucid Diagnostics (NASDAQ: LUCD) closes $18M underwritten stock sale - Stock Titan
Lucid Diagnostics Closes $18 Million Share Offering - Intellectia AI
Lucid Diagnostics prices $18M stock offering at $1 per share - Investing.com India
Lucid Diagnostics closes $18M stock offering at $1 per share By Investing.com - Investing.com South Africa
Lucid Diagnostics Prices $18 Million Public Equity Offering - TipRanks
Lucid Diagnostics (LUCD) raises $18M with 18M-share offering (NASDAQ: LUCD) - Stock Titan
Lucid Diagnostics Prices $18 Million Underwritten Offering at $1 Per Share With Canaccord and BTIG - TradingView
Lucid Diagnostics (Nasdaq: LUCD) prices $18M underwritten stock sale - Stock Titan
Lucid Diagnostics prices 18M shares at $1.00 in registered direct offering - TipRanks
Lucid Diagnostics prices $18M stock offering at $1 per share By Investing.com - Investing.com South Africa
Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock - PR Newswire
Lucid Diagnostics (LUCD) Annual Recap | Lucid Diagnostics posts 2% EPS beat, beats consensus loss estimatesDividend Cut Risk - Xã Vĩnh Công
Lucid Diagnostics Prices Registered Direct Offering of 18 Million Shares - Moomoo
Lucid Diagnostics (NASDAQ: LUCD) seeks 100M-share authorization increase - Stock Titan
Lucid Diagnostics (LUCD) Stock: Why It Matters Now (+3.20%) 2026-04-20Risk Management - Xã Vĩnh Công
Needham Reiterates Lucid Diagnostics (LUCD) Buy Recommendation - MSN
Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Needham Maintains Lucid Diagnostics(LUCD.US) With Buy Rating, Maintains Target Price $3 - 富途牛牛
Victoria Tou Ho Lee Net Worth (2026) - GuruFocus
Lucid Diagnostics Outperforms Pressure BioSciences in Key Metrics - National Today
Lucid Diagnostics (LUCD) CMO holds 650K shares including restricted stock - Stock Titan
Layoff Watch: Whats the MACD signal for Lucid Diagnostics Inc2026 Analyst Calls & Long Hold Capital Preservation Plans - baoquankhu1.vn
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025 - Quantisnow
Fed Meeting: Is Lucid Diagnostics Inc stock forming a cup and handle2026 PreEarnings & Community Consensus Picks - baoquankhu1.vn
Dividend Watch: Can Lucid Diagnostics Inc be recession proofTrade Exit Report & Precise Swing Trade Alerts - baoquankhu1.vn
Ascendiant Maintains Lucid Diagnostics(LUCD.US) With Buy Rating, Raises Target Price to $9 - Moomoo
Breakout Move: What is the next catalyst for Lucid Diagnostics Inc2026 Performance Recap & Daily Profit Maximizing Tips - baoquankhu1.vn
Lucid Diagnostics to Participate in Needham Healthcare Conference - National Today
Lucid Diagnostics to Participate in Fireside Chat at the 25th An - GuruFocus
Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference - Bitget
Lucid Diagnostics to Participate in Fireside Chat at Healthcare Conference - National Today
Lucid Diagnostics CEO to Participate in Healthcare Conference - Intellectia AI
Lucid Diagnostics Inc. $LUCD Shares Purchased by Aberdeen Group plc - MarketBeat
Lucid CEO to speak at Needham healthcare conference on April 16 - Stock Titan
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q3 2025 Earnings Call Transcript - MSN
Is Lucid Diagnostics (LUCD) Stock Slowing Down | Price at $1.15, Up 2.23%Money Flow - Cổng thông tin điện tử tỉnh Lào Cai
Aug Action: Whats the MACD signal for Lucid Diagnostics Inc2026 Earnings Surprises & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
LUCD PE Ratio & Valuation, Is LUCD Overvalued - Intellectia AI
Lucid Diagnostics Inc. (LUCD) stock price, news, quote and history - Yahoo Finance UK
Lucid Diagnostics Inc (LUCD) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):